·
5 Min Read

June 19, 2020: State Advocacy Update

AMA urges CDC to make significant revisions to opioid prescribing guideline and more State Advocacy news.

Advocacy Update
·
2 Min Read

AMA urges CDC to revise opioid prescribing guideline

To make meaningful progress toward ending this epidemic, a broad-based public health approach is required.

Press Releases
·
2 Min Read

May 29, 2020: State Advocacy Update

New research highlights need to remove barriers for patients with opioid use disorder and more in the latest State Advocay Update.

Advocacy Update
·
11 Min Read

Experts discuss the pandemic’s impact on the opioid epidemic

The AMA is leading the fight against the COVID-19 pandemic. See the latest daily video update on how the COVID-19 pandemic has impacted the opioid epidemic.

series
Behavioral Health
AMA Update
Poster for naloxone
·
6 Min Read

COVID-19 may be worsening opioid crisis, but states can take action

The pandemic is exacerbating the ongoing opioid epidemic. The AMA is calling on states to take specific steps to save lives, reduce harm and get patients treatment they need.

Behavioral Health
·
2 Min Read

May 22, 2020: State Advocacy Update

State reports of increased opioid-related mortality continue to increase in the latest State Advocacy Update.

Advocacy Update
·
2 Min Read

May 15, 2020: State Advocacy Update

Opioid epidemic may be worsening; states must implement federal flexibility in the latest State Advocacy Update.

Advocacy Update
·
10 Min Read

April 17, 2020: National Advocacy Update

Advocacy spotlights new cyber treats during COVID-19 and physician protections as well as new policies for opioid treatment programs.

Advocacy Update
Man wearing a face mask
·
3 Min Read

New policies on treating pain, OUD emerge from COVID-19 crisis

The DEA is allowing qualified physicians to prescribe buprenorphine over the telephone so patients can stay home. The AMA urges states to do the same.

Behavioral Health